via telegraph.co.uk
Some 11 of the 12 drugs approved by the Food and Drug Administration in the US in 2012 were priced above $100,000 (£65,000) per patient per year, with the price of existing drugs that have proven effectiveness rising by up to threefold, the Independent reported.
No comments:
Post a Comment